Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients

[Background] The combination of alpha-fetoprotein (AFP) and squamous cell carcinoma antigen immunocomplex (SCCA-IgM) have been proposed for its use in the screening of hepatocellular carcinoma (HCC). Current screening programs for all cirrhotic patients are controversial and a personalized screening...

Descripción completa

Detalles Bibliográficos
Autores: Gil-Gómez, Antonio, Rojas, Ángela, Liu, Chang-Hai, Gallego-Durán, Rocío, Muñoz-Hernández, Rocío, Fassina, Giorgio, Pontisso, Patrizia, Ampuero, Javier, Romero-Gómez, Manuel
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/269413
Acceso en línea:http://hdl.handle.net/10261/269413
Access Level:acceso abierto
Palabra clave:Squamous cell carcinoma antigen
Hepatocellular carcinoma prediction
Precision medicine
Stratification of cirrhotic patient
Descripción
Sumario:[Background] The combination of alpha-fetoprotein (AFP) and squamous cell carcinoma antigen immunocomplex (SCCA-IgM) have been proposed for its use in the screening of hepatocellular carcinoma (HCC). Current screening programs for all cirrhotic patients are controversial and a personalized screening is an unmet need in the precision medicine era.

Similares en LA Referencia